Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2012
03/28/2012CN101522736B Comb polymers and use thereof for the production of active or effective ingredient formulations
03/28/2012CN101502562B Medicament composition for protecting and promoting regeneration function of hepatocyte and preparation method
03/28/2012CN101485652B Composition of taxone compound, and preparation method and application thereof
03/28/2012CN101455773B China root greenbrier dispersible tablet and preparation method thereof
03/28/2012CN101439087B Chinese medicine granule containing salvia root extract and preparation method thereof
03/28/2012CN101439078B Chinese medicine granule containing astragalus extract and preparation method thereof
03/28/2012CN101411715B Pharmaceutical composition containing acarbose
03/28/2012CN101337070B Freeze-dried attenuated live vaccine for hepatitis A and its preparing process
03/28/2012CN101336906B Patch and patch preparation
03/28/2012CN101292951B Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof
03/28/2012CN101291678B Carrier composition for nucleic acid transport
03/28/2012CN101264320B Oxygen-carrying blood substitute preparations
03/28/2012CN101184499B Intranasal administration of active agents to the central nervous system
03/28/2012CN101121519B Hollow silicon dioxide sub-micron sphere with inner core and its preparation method and use
03/28/2012CN101035563B Multimeric VLA-4 antagonists comprising polymer moieties
03/27/2012US8143378 Polymer factor VIII moiety conjugates
03/27/2012US8143317 Use of xenon for treating neurointoxications
03/27/2012US8143312 Transparent eye drops containing latanoprost
03/27/2012US8143239 Composition for inhalation
03/27/2012US8143215 Method of promoting weight loss
03/27/2012US8143062 Method and composition for enhancing weight loss
03/27/2012US8142812 Chemical carrier based on a beta-limit dextrin
03/27/2012US8142809 Compositions and methods to lower glycohemoglobin levels
03/27/2012US8142808 Hydrogel substrate with porous surfaces; attaching biomaterials to living tissue; load bearing inserts; tissue repair and regeneration; disk prosthetics
03/27/2012US8142790 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
03/27/2012US8142784 Antibody-drug conjugates and methods
03/27/2012US8142776 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations
03/27/2012US8142763 Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining
03/27/2012CA2606370C Self-preserved aqueous pharmaceutical compositions
03/27/2012CA2540917C Polyarginine-modified liposome having nuclear entry ability
03/27/2012CA2527141C Polyhydroxy phenols and their use in binding p-selectin
03/27/2012CA2521784C Reversible pegylated drugs
03/27/2012CA2494796C Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
03/27/2012CA2473669C Use and preparation of dosage forms containing benzimidazole derivatives and a buffer
03/27/2012CA2454699C Method for treating primary insomnia
03/27/2012CA2431487C Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/22/2012WO2012037534A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012WO2012037530A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph
03/22/2012WO2012037380A2 Formulations of guanylate cyclase c agonists and methods of use
03/22/2012WO2012037358A1 Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
03/22/2012WO2012037078A2 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
03/22/2012WO2012036589A1 Hydrogel composition for the treatment of burns
03/22/2012WO2012036585A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
03/22/2012WO2012036257A1 Composition for maintaining platelet function
03/22/2012WO2012036080A1 Bitterness-masking ingredient and bitterness-masking method
03/22/2012WO2012036078A1 Drug-containing film-coated particles in which unpleasant taste is masked
03/22/2012WO2012035794A1 Octreotide-modified nano preparation for treatment of cancer or palliative care of cancer
03/22/2012WO2012035685A1 Composition for promoting hyaluronic acid production
03/22/2012WO2012035516A1 Fulvestrant compositions and methods of use
03/22/2012WO2012035480A2 Pharmaceutical compositions of curcumin
03/22/2012WO2012035381A1 A novel dermaceutical cream made using sodium fusidate and betamethasone valerate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035380A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035379A1 A novel dermaceutical cream made using sodium fusidate, miconazole nitrate and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035378A1 A dermaceutical cream made using sodium fusidate, and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035377A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035375A1 A novel dermaceutical cream made using sodium fusidate and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035364A1 Stabilized solution of ortho-silicic acid, its preparation and use
03/22/2012WO2012035283A1 Pharmaceutical composition
03/22/2012WO2012035139A1 Prodrugs comprising an exendin linker conjugate
03/22/2012WO2012035037A1 Method for purifying pegylated erythropoietin
03/22/2012WO2012034379A1 Method for preparing ph sensitive metal organic coordination polymer
03/22/2012WO2012013994A3 Ph-dependent gradual release pharmaceutical composition
03/22/2012WO2012013366A3 Preventive bactericidal polish for nail treatment
03/22/2012WO2011151356A3 Methods for the preparation of injectable depot compositions
03/22/2012WO2011149814A3 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
03/22/2012WO2011142858A9 Chlorotoxin variants, conjugates, and methods for their use
03/22/2012WO2011141929A3 Aqueous pharmaceutical compositions of fluticasone and olopatadine
03/22/2012WO2011139101A3 Method for producing the solid phase of a water-insoluble gel composition and a water-insoluble gel produced thereby
03/22/2012WO2011133925A3 Targeted and light-activated cytosolic drug delivery
03/22/2012WO2011116286A3 Stable bortezomib formulations
03/22/2012WO2011097149A3 Taxane-and taxoid-protein compositions
03/22/2012WO2011089604A3 Material and method for treating internal cavities
03/22/2012WO2011019718A3 Personal care composition with improved spreadability
03/22/2012WO1996002235A9 Injectable res avoiding inorganic particles
03/22/2012US20120071627 Soluble, Degradable Poly(ethylene glycol) Derivatives for Controllable Release of Bound Molecules into Solution
03/22/2012US20120071570 Novel acyl acidic amino acid ester
03/22/2012US20120071569 Process for producing gel of carboxymethyl cellulose alkali metal salt
03/22/2012US20120071567 Fruit flavored cocoa butter based confection
03/22/2012US20120071566 Bioabsorbable Polymeric Compositions, Processing Methods, and Medical Devices Therefrom
03/22/2012US20120071565 Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071510 Method and Composition for Treating Migraines
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071409 Colloidal Liposomal Compositions and Methods
03/22/2012US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
03/22/2012US20120070487 Alkylsaccharide compositions with nutraceuticals
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070453 Methods for Preparing and Delivering Adjuvant Compositions
03/22/2012US20120070384 Topical antifungal composition
03/22/2012US20120070383 Polymeric nano-carriers with a linear dual response mechanism and uses thereof
03/22/2012US20120067361 Plant fiber product and method for its manufacture
03/22/2012CA2848656A1 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
03/22/2012CA2811504A1 Composition for maintaining function of platelets
03/22/2012CA2811494A1 Octreotide-modified nanomedicine for cancer treatment or cancer palliative care
03/22/2012CA2811352A1 Prodrugs comprising an exendin linker conjugate
03/22/2012CA2811258A1 Fulvestrant compositions and methods of use
03/22/2012CA2810734A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012CA2810731A1 Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral ph
03/22/2012CA2810598A1 Pharmaceutical composition
03/22/2012CA2810243A1 Formulations of guanylate cyclase c agonists and methods of use
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 1712